Comment from Veeva Systems

Summary: Veeva Systems, a life sciences software provider, supports the proposed Expedited IND Pilot Program and urges the FDA to include technology partners in the initiative. They argue that a single, streamlined technology platform is essential for standardizing data, ensuring auditability, and enabling cross-QRI comparison.